mirtazapine has been researched along with Cystic Fibrosis of Pancreas in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Adequate dosage forms are essential for achieving successful pharmacotherapy." | 2.42 | Benefits of different drug formulations in psychopharmacology. ( Frijlink, HW, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frijlink, HW | 1 |
1 review available for mirtazapine and Cystic Fibrosis of Pancreas
| Article | Year |
|---|---|
Benefits of different drug formulations in psychopharmacology.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Circadian Rhythm; Cystic Fibrosis; Drug Administra | 2003 |